Cynthia Behling

3.6k total citations · 2 hit papers
27 papers, 2.2k citations indexed

About

Cynthia Behling is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Cynthia Behling has authored 27 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 12 papers in Hepatology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Cynthia Behling's work include Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (7 papers) and Diet, Metabolism, and Disease (6 papers). Cynthia Behling is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Liver Disease and Transplantation (7 papers) and Diet, Metabolism, and Disease (6 papers). Cynthia Behling collaborates with scholars based in United States, Spain and Japan. Cynthia Behling's co-authors include Joel E. Lavine, Jeffrey B. Schwimmer, Claude B. Sirlin, Aynur Ünalp, Rohit Loomba, David E. Kleiner, Laura Wilson, Brent A. Neuschwander‐Tetri, Elizabeth M. Brunt and Kimberly P. Newton and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Cynthia Behling

26 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

2024 353 citations Rohit Loomba, Mark L. Hartman et al. New England Journal of Medicine profile →
A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

2022 162 citations Veeral Ajmera, Heather Hofflich et al. Journal of Hepatology profile →

Peers

Cynthia Behling

EPIDE

EDM

HEPAT

SURGE

PHYSI

Matilde Marcellini Italy

Björn Roelstraete Sweden

Andrea Pietrobattista Italy

Rachel M. Brown United Kingdom

Stephen E. Congly Canada

Melanie Beaton Canada

Kristian Bjøro Norway

Gioconda Saccoccio Italy

Münevver Demir Germany

John Lubel Australia

Matilde Marcellini Italy

Cynthia Behling

2.3k ×1.4

EPIDE

1.0k ×1.2

EDM

1.2k ×1.6

HEPAT

622 ×1.6

SURGE

307 ×1.3

PHYSI

Citations per year, relative to Cynthia Behling Cynthia Behling (= 1×) peers Matilde Marcellini

Countries citing papers authored by Cynthia Behling

Since Specialization

Citations

This map shows the geographic impact of Cynthia Behling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Behling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Behling more than expected).

Fields of papers citing papers by Cynthia Behling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cynthia Behling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Behling. The network helps show where Cynthia Behling may publish in the future.

Co-authorship network of co-authors of Cynthia Behling

This figure shows the co-authorship network connecting the top 25 collaborators of Cynthia Behling. A scholar is included among the top collaborators of Cynthia Behling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cynthia Behling. Cynthia Behling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Newton, Kimberly P., Amanda L. Blackford, Cynthia Behling, et al.. (2025). Longitudinal response to standard of care in pediatric metabolic dysfunction–associated steatotic liver disease: Rates of improvement and worsening, and factors associated with outcomes. Hepatology. 82(5). 1198–1210. 3 indexed citations

Newton, Kimberly P., Laura Wilson, Stavra A. Xanthakos, et al.. (2025). Longitudinal Analysis of Liver Chemistry Trajectories and Risk of Type 2 Diabetes in Children With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Multicenter Cohort Study. Diabetes Care. 49(4). 598–606.

Loomba, Rohit, Mark L. Hartman, Eric Lawitz, et al.. (2024). Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis. New England Journal of Medicine. 391(4). 299–310. 353 indexed citations breakdown →

Ratziu, Vlad, Marcus Hompesch, Janani Iyer, et al.. (2023). Artificial intelligence-assisted digital pathology for non-alcoholic steatohepatitis: current status and future directions. Journal of Hepatology. 80(2). 335–351. 47 indexed citations

Palmer, Melissa, David E. Kleiner, Zachary Goodman, et al.. (2023). Liver biopsy for assessment of suspected drug‐induced liver injury in metabolic dysfunction‐associated steatohepatitis clinical trials: Expert consensus from the Liver Forum. Alimentary Pharmacology & Therapeutics. 59(2). 201–216. 8 indexed citations

Ajmera, Veeral, Heather Hofflich, Scarlett Lopez, et al.. (2022). A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. Journal of Hepatology. 78(3). 471–478. 162 indexed citations breakdown →

Sanyal, Arun J., Stephen A. Williams, Joel E. Lavine, et al.. (2022). Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease. Journal of Hepatology. 78(4). 693–703. 48 indexed citations

Filozof, Claudia, Carolin Lackner, Manuel Romero‐Gómez, et al.. (2022). Best Practices in Liver Biopsy Histologic Assessment for Nonalcoholic Steatohepatitis Clinical Trials: Expert Opinion. IUScholarWorks (Indiana University). 2022. 1–11. 5 indexed citations

Tamaki, Nobuharu, Nagambika Munaganuru, Jinho Jung, et al.. (2021). Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut. 71(5). 983–990. 72 indexed citations

10.

Sharpton, Suzanne R., Nobuharu Tamaki, Ricki Bettencourt, et al.. (2021). Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology. 14. 1088233412–1088233412. 23 indexed citations

11.

Newton, Kimberly P., Joel E. Lavine, Laura Wilson, et al.. (2020). Alanine Aminotransferase and Gamma‐Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis. Hepatology. 73(3). 937–951. 45 indexed citations

12.

Mueller, Noel T., Tiange Liu, Katherine P. Yates, et al.. (2020). Sex Hormone Relations to Histologic Severity of Pediatric Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism. 105(11). 3496–3504. 29 indexed citations

13.

Newton, Kimberly P., Jiayi Hou, Nancy A. Crimmins, et al.. (2016). Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. JAMA Pediatrics. 170(10). e161971–e161971. 173 indexed citations

14.

Mosli, Mahmoud, Brian G. Feagan, William J. Sandborn, et al.. (2014). Histologic Evaluation of Ulcerative Colitis. Inflammatory Bowel Diseases. 20(3). 564–575. 80 indexed citations

15.

Mosli, Mahmoud, Brian G. Feagan, Guangyong Zou, et al.. (2014). Sa1192 Agreement of Central Readers in the Evaluation of Histopathological Disease Activity in Ulcerative Colitis. Gastroenterology. 146(5). S–225. 1 indexed citations

16.

Awai, Hannah I., Kimberly P. Newton, Claude B. Sirlin, Cynthia Behling, & Jeffrey B. Schwimmer. (2013). Evidence and Recommendations for Imaging Liver Fat in Children, Based on Systematic Review. Clinical Gastroenterology and Hepatology. 12(5). 765–773. 103 indexed citations

17.

Kistler, Kristin D., Jean P. Molleston, Aynur Ünalp, et al.. (2009). Symptoms and quality of life in obese children and adolescents with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics. 31(3). 396–406. 71 indexed citations

18.

Brunt, Elizabeth M., David E. Kleiner, Laura Wilson, et al.. (2008). Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD). Hepatology. 49(3). 809–820. 288 indexed citations

19.

Kleiner, David E., Elizabeth M. Brunt, Cynthia Behling, et al.. (2003). 160 Design and validation of a histologic scoring system for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Hepatology. 38. 233–233. 16 indexed citations

20.

Lonergan, J Tyler, et al.. (2000). Hyperlactatemia and Hepatic Abnormalities in 10 Human Immunodeficiency Virus-Infected Patients Receiving Nucleoside Analogue Combination Regimens. Clinical Infectious Diseases. 31(1). 162–166. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact